Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $46.40 USD
Change Today +1.80 / 4.04%
Volume 785.4K
NUVA On Other Exchanges
As of 8:10 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin C. O'Boyle

Former Executive Vice President, NuVasive, Inc.
AgeTotal Calculated CompensationThis person is connected to 42 board members in 6 different organizations across 9 different industries.

See Board Relationships


Mr. Kevin C. O'Boyle served as Chief Financial Officer and Senior Vice President at Advanced BioHealing, Inc. (now known as Shire Regenerative Medicine, Inc.) since December 2010. Mr. O'Boyle served as the Interim Chief Financial Officer of GenMark Diagnostics, Inc. since November 10, 2011. He served as an Executive Vice President of NuVasive, Inc. from December 2004 to December 2009. He served as the Chief Financial Officer of NuVasive, Inc., from January 2003 to his ...

Read Full Background

Corporate Headquarters*

7475 Lusk Boulevard
San Diego, California 92121

United States

Phone: 858-909-1800
Fax: 800-475-9134

Board Members Memberships*

Non-Executive Director, Chairman of Audit Committee and Member of Compensation Committee
Non-Executive Director, Member of Audit Committee and Member of Nominating & Governance Committee
Non-Executive Director, Chairman of Strategic Transactions Committee, Member of Audit Committee and Member of Nominating, Corporate Governance & Compliance Committee
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee


Rochester Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$92,496
Total Calculated Compensation$122,498
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NUVA:US $46.40 USD +1.80


John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUVASIVE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at